Review Article
Print
Review Article
The effect of a small polyphenolic and terpenoids phytochemical constituent on curing and preventing of Covid-19 infections
expand article infoSaif Aldeen Jaber§
‡ Middle East University, Amman, Jordan
§ Applied Science Private University, Amman, Jordan
Open Access

Abstract

Covid-19 spreading have caused millions of deaths worldwide and caused sever economic shrinking resulted in high levels of inflations. The on going pandemic has pushed the pharmaceutical companies to invent different vaccines to overcome the spreading of the virus and to reduce its effect on health and economy. Unfortunately, the middle and low income countries have been struggling in providing vaccines to their people due to the high expenses associated with vaccines ordering. Thus, the interest in finding a treatment and a prevention of Covid-19 from natural products has increased not in those countries only, even in high income countries. In this review we investigated the promising natural phytochemical compounds and their published mechanism of action in a prestigious peer-reviewed research journal throw different molecular docking and in vivo and vitro techniques. Its was found that the consumption of the medicinal plants containing small phenolic and terpenoids phytoconstituent like as thymoquinone, quercetin, caffeic acid, ursolic acid, ellagic acid, vanillin, and thymol have a great therapeutic effect for curing and preventing viral infections. This review has focused on the small polyphenolic and terpenoids compounds and their potential and mechanism activity against SARS-CoV-2. Our comprehensive analysis provides mechanistic insight into plant components for virus containment prevent infections and provide better solutions through natural therapeutically active ingredients.

Keywords

Covid-19, Medicinal plants, Anti-viral, Polyphenols

Introduction

The emotional alter of occasions with the later exceptional coronavirus pandemic announced by the World health organization (GBHWHO) has incited an exponential increment of logical intrigue in coronaviruses globally (https://www.who.int/emergencies/diseases/novel-coronavirus-2019). As of December 2022, the widespread has resulted in hundreds of millions of infections, with tens of millions passings around the world, which reduced by a matter of time but unfortunately still between us (Jaber 2023). Coronaviruses (CoVs) have a place to the family Coronaviridae, subfamily Coronavirinae and are expansive (genome measure 26−32 kb) wrapped, positive-sense single-stranded ribonucleic corrosive (RNA) viruses that can contaminate both creatures and people (Fig. 1). Based on their genotypic and serological characteristics, the infections are subdivided into four genera: Alpha-, Beta-, Gamma-, and Delta-coronavirus (Lu et al. 2015; Chu et al. 2020; Wu et al. 2020a). At display, all distinguished CoVs that are capable of tainting people have a place to the primary two genera. These include the alpha-coronaviruses (αCoVs) HCoV-NL63 (Human CoV-NL63) and HCoV-229E and the beta-coronaviruses (βCoVs) HCoV-OC43 (Human CoV-OC43), HKU1 (Human CoV), SARS-CoV (Serious Acute Respiratory Disorder CoV), and MERS-CoV (Center Eastern Respiratory Syndrome CoV) (Lu et al. 2015). Within the past two decades there have been three scourges caused by the betaCoVs, specifically SARS in 2002−03, MERS in 2012 and COVID-19, to begin with recognized in 2019 (Yang et al. 2020b). SARS-CoV developed in 2002−03 in Southern China, causing a global danger and tainting more than 8000 individuals, with approximately 800 fatalities recorded, to a great extent in China and the encompassing regions (Pawlotsky 2014; Lu et al. 2015). MERS-CoV developed in the Middle East, spreading to a few nations to contaminate near to 2300 individuals, resulting in 845 passings as of July 2019 (WHO 2020). The new CoV widespread coming about from SARS-CoV- 2, which causes COVID-19 (Chauhan 2020).

Figure 1. 

The common structure of a coronavirus (replicated from Wikipedia beneath CC permit 4.0). E protein = envelope protein.

The main druggable targets of SARS-CoV-2 incorporate 3-chymotrypsin- like protease (3CLpro), papain-like protease (PLpro), RNA-dependent RNA polymerase, and spike (S) proteins (Wu et al. 2020b). The S proteins interact directly with a human angiotensin-converting enzyme (ACE) 2, allowing the virus to enter the cells. At present, no preventive vaccines or established antiviral therapies are available for coronaviruses (Sohrabi et al. 2020). In any case, a few manufactured compounds have appeared guarantee, counting hydroxychloroquine and choloroquine phosphate which act through a few components, counting alkalisation of the host cell phagolysosomes (Cortegiani et al. 2020). More current antiviral drugs such as lopinavir, remdesivir, and arbidol oo appear to guarantee (Khamitov et al. 2008).Other suggested treatment alternatives incorporate lopinavir/ritonavir, nucleoside analogues, neuraminidase inhibitors, and peptide EK1 (Yang et al. 2020a). A nitty gritty list of current and arranged clinical trials examining different drugs for the treatment of SARS-CoV-2 was given by Throb et al. (2020), with updated comes about accessible from ClinicalTrials.gov (2020) (Pang et al. 2020). In addition, traditional herbal remedies and isolated natural compounds can lead to the development of new and novel antiviral agents. Thus, usually its more efficient to design drugs based on already discovered natural compounds with known and relatively close biological and mechanistic activity. Indeed, most of the approved drugs approved between 1981–2014 are derived or designed based on the natural product (Newman and Cragg 2016; Jaber 2021). Besides, within the current outbreak of COVID-19, numerous patients show up to be turning to complementary or conventional restorative treatments, yet utilizing them almost only in conjunction with western pharmaceutical. For example, one think about recommended that nearly 92 % of 135 hospitalized patients in northeast Chonqing (China) gotten conventional Chinese pharmaceuticals in addition to western pharmaceuticals (Wan et al. 2020; Jaber and Saadh 2023). However, most researchers have stated in their conducted research about the hardness of isolating compounds in addition to the possible drug-drug interaction with synthetic drugs (Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (Zhang et al. 2020; Saadh and Jaber 2022). This review summarizes the therapeutic properties of essential phytoconstituents, polyphenols, alkaloids, like thymoquinone, quercetin, caffeic acid, ursolic acid, etc., and further discusses their therapeutic potential in COVID-19.

Thymoquinone inhibits the CoV-2

Nigella sativa can produce a wide range of bioactive compounds like thymoquinone and nigellimine that can be used in COVID-19 treatment by preventing the virus from contacting the possible host cells by changing the ionophores to improve zinc levels that enhance cells immunity (Ali et al. 2022).The main active ingredients reported in the literature have numerous biological activities such as immune regulatory, anti-inflammatory, anti-oxidant, anti-microbial, anti-tumour, analgesic, and hepatoprotective (Banerjee et al. 2009; Chaieb et al. 2011; Khader and Eckl 2014; Ahmad et al. 2019). Thymoquinone has been found to inhibit 5-lipooxygenase, leukotriene B4, C4, and Th2 cytokines in the lungs that improve immunity by increasing the number of immune cells number in lung tissue (El Gazzar et al. 2006; Rana et al. 2021b). The anti-inflammatory activity of the mentioned compound is regulated by hem oxygenase 1 and human keratinocyte cells (Khader and Eckl 2014). Moreover, the molecular docking-based studies illustrated before have found nigellidine and α-hederin to be able to incorporate with SARS-CoV-2 (Xu et al. 2021). N. sativa extracts clearly provide better activity as it has mechanisms of action due to the presence of many bioactive compounds.

Quercetin-mediated inhibition

Quercetin (3,3′ ,4′5,7-pentahydroxyflavone), is a flavonoid compound found in many plants consumed by humans such as apples, berries, grapes, onions, and tea, especially the green one (Ali et al. 2022). Quercetin is a poly-phenolic compound with a wide variety of biological activities including anti-oxidant, anti-inflammatory, anti-cancers, anti-viral, anti-bacterial, and immunity enhancer in addition to be used as a positive control in many biological testing for its activities (Henson et al. 2007; Nieman et al. 2007; Heinz et al. 2010; Yousuf et al. 2020). Previous studies illustrated in vivo and in vitro experiments have shown an immune-modulating activity that leads to an increase in the chemotaxis motion of neutrophils, phagocytosis, and the proliferation of immune cells that enhance the immune system(Henson et al. 2008). In addition, health workers and doctors used to recommend quercetin to improve the immune system of common people and sports professionals to reduce the risk of infections, especially with severe physical activities (Henson et al. 2007; Aucoin et al. 2020). Regarding anti-viral activity, quercetin has been reported to exert a potential and promising anti-viral activity by inhibiting viral proteases, reverse transcriptase, polymerase and binding viral capsid portions in addition to suppressing DNA gyrase (Shinozuka et al. 1988; Spedding et al. 1989; Refaat et al. 2021; Singh et al. 2021a). Regarding quercetin and SARS-CoV-2, it was found that quercetin is inhibiting the propylitic activity of 3CL protease with IC50 of 4.95µM (Colunga Biancatelli et al. 2020).

Caffeic acid effect on virus attachments

Caffeic acid is another polyphenolic compound isolated from natural source and listed as a part of phenolic acid family. Its one of the main hydroxycinnamic acid with a molecular weight of 180.16g/mol (Son and Lewis 2002; Paracatu et al. 2014). Caffeic acid can be present in a high concentration inside many medicinal plants or fruits like blueberries, kiwis, coffee, cherries, apples, oils, and tea (El-Seedi et al. 2012; Sova and Saso 2020). Caffeic acid and its derivatives have high protectives and curing abilities due to different biological activity such as, antioxidant, anti-inflammatory, anti-bacterial and anti-viral activities (Silva and Lopes 2020; Ali et al. 2021; Rana et al. 2021a). previously caffeic acid has been reported to exert a potential biological activity against different viruses such as, influenza, herpes simplex, and severe fever with thrombocytopenia syndrome viruses (Utsunomiya et al. 2014; Ogawa et al. 2018). In addition to its activity, caffeic acid and its derivatives have been used by different research companies to find a treatment for HIV, human sarcoma, polio and influenza viruses (Ali et al. 2022). Caffeic acid and its derivatives have been screened to find a novel therapeutic activity of it against SARS-CoV-2 (Ali et al. 2022). Thus, many targets have been found such as spike ectodomain (open), spike glycoprotein (closed), Nsp15 endoribonuclease, Mpro (6LU7), and S2 subunit (6LXT), have been subjected to the study. The analysis has identified several CAFDs as modulators of SARS-CoV-2 drug targets, in particular, khainaoside C as Mpro modulator, khainaoside B as SARS-CoV-2 fusion protein, 6-O-Caffeoylarbutin as Nsp15, khainaoside C as spike (open), and vitexfolin A as spike (closed) modulator (Adem et al. 2021).

Ursolic acid inhibitory activity for Mpro enzyme

Ursolic acid is a pentacyclic triterpenoid compound isolated from ethanolic extracts of natural source (Kashyap et al. 2016; Hussain et al. 2017; Pironi et al. 2018; López-Hortas et al. 2018). Ursolic acid mainly isolated from Mimusopscaffra, Ilex paraguarieni, and Glechoma hederacea and was reported to exert anti-inflammatory, anti-bacterial, anti-oxidant, anti-diabetic, and anti-cancer biological activity (Pironi et al. 2018; Mlala et al. 2019; Alam et al. 2021a; Alam et al. 2021b; Singh et al. 2021b). During Covid-19, ursolic acid was tested against SARS-CoV-2 Mpro enzyme and was successfully active by inhibition of the mentioned enzyme (Ali et al. 2022). In addition, a molecular docking and molecular dynamic simulation study has confirmed the ability of ursolic acid and its derivatives to protease during 50 ns of MD simulation (Kumar et al. 2021). Ursolic acid show high binding affinity by forming a hydrogen bond with amino group of the Asp 108 found in PLpro protease enzyme and with hydrophobic interaction on Ala 107, Pro 248, and Tyr 264 of the same enzyme (Mitra et al. 2021).

Ellagic acid effect on Mpro and RdRp enzymes

Ellagic acid a small polyphenolic molecule with a molecular weight of 302.197 g/mol that can be found in many types of fruits and vegetables (Malini et al. 2011; Saeed et al. 2018; Evtyugin et al. 2020). In addition to the ellagic acid, a hydrolysable derivative ellagitannins found in many fruits such as raspberries, strawberries, pomegranate, grapes, green tea, and almond have found to be biologically active as anti-oxidant, and anti-proliferative with high health potential (García-Niño and Zazueta 2015; Derosa et al. 2016). Moreover, ellagic acid was found to obstruct tumour cells migration, and angiogenesis with potential activity to inhibit oxidative stress, and inflammation in diabetic rats (Sanati et al. 2022, Xiao et al. 2022, Núñez et al. 2023). In many studies mentioned before, the small polyphenolic molecules have a potential inhibitory activity against the main protease for SARS-CoV-2 Mpro enzyme with a high potential for being a treatment option for infectious diseases (Saadh and Jaber 2022, Souid et al. 2022, Ghamry et al. 2023, Jaber and Saadh 2023a). In other studies, ellagic acid was found to show a high binding with Mpro enzyme at the catalytic site with Cys145 (Adelusi et al. 2022). Another study performed on 14 phenolic compounds and terpenes including quercetin and ellagic acid show the ability of the mentioned compounds to interact with RNA-dependant RNA-polymerase (RdRp) enzyme of SARS-CoV-2 on molecular docking software (Ali et al. 2022).

Vanillin inhibitory activity to Mpro enzyme

Vanillin is a naturally occurring compound used in different industrial sectors like food, perfumes, and pharmaceuticals industries (Ali et al. 2022). Vanillin is a small phenolic molecule that extracted from the vanilla bean and used as an intermediate molecule for other essential molecules. Its well known that vanillin has a very important biological activites due to its chemical structure such as, anti-microbial, anti-oxidant, and ant-clastogenic activity (Naz et al. 2018; Yousuf et al. 2021). The potential anti-microbial activity and anti-oxidant activity of vanillin with its small molecular structure have pushed the medicinal chemist to apply molecular docking to it for evaluation (Tai et al. 2011; Yadav et al. 2018; Yadav 2021). It was reported that vanillin and some related molecules are good starting point for the discovery of a new compound against SARA-CoV-2 virus (Law et al. 2020).

Thymol inhibitory effect on spike protein

Thymol is another small phenolic monoterpene molecule that isolated from the medicinal plant Thymus vulgaris and also can be found in another plants with a lower concentration. Its will known that thymol is used excessively by people due to its multi-functional role for human health as anti-viral, anti-bacterial, anti-fungal, anti-oxidant, anti-septic, anti-cancer and more. The development of nano-capsule has expanded the using of thymol in health care and enhance its biological activity (Marchese et al. 2016; Kowalczyk et al. 2020; Turab Naqvi et al. 2020). During Covid-19 crise, thymol was one of the compound enrolled in a molecular docking study performed by Kulkarni et al and found to exert a potential binding with S1 of spike glycoprotein (Kulkarni et al. 2020). In addition, another in silico study was performed using18 compounds including thymol and reported its activity against transmembrane protease serine 2 (TMPRSS2) that resulted in the cleavage of SARS-CoV-2 Spike protein (Yadav et al. 2022).

Conclusion and future prospect

In the present unfavourable of the new spreading of SARS-CoV-2 in middle and low income countries, there is an urgent need to used natural products as a therapeutic alternative to vaccines to prevent viral infections and to enhance human immunity. Due to the time-consuming process for the search of a new natural compounds with anti-Covid-19 activity its important to start with a well known compounds with their biological activity such as compounds presented in Table 1.

Table 1.

List of already known natural compounds proved to exert activity against SARS-CoV-2.

Compound Biological activity Activity against Covid-19 Natural source Reference
Thymoquinone Anti-oxidant immune-regulatory, anti-inflammatory, and anti-oxidant. Prevent the SARS-CoV-2 entry; inhibits viral replication Nigella sativa (Elfiky 2021)
Quercetin Anti-oxidant, anti-inflammatory, anti-cancerous, anti-viral, anti-bacterial, and immunomodulatory Inhibition of 3CL protease activity and viral entry inside the host cell Apples, Honey, Raspberries, Onions, Red Grapes, Cherries, Citrus Fruits, and Green Leafy Vegetables (Grochowicz et al. 1988)
Caffeic Acid Anti-oxidant, anti-inflammatory, anti-bacterial and anti-viral Inhibit the virus attachment to the host cell; Binds 3CL protease inhibits the viral replication Blueberries, Kiwis, Coffee, Cherries, Apples, Oils, and Tea (Ogawa et al. 2018)
Ursolic Acid Anti-inflammatory, anti-bacterial effects, anti-oxidant, anti-cancer, and anti-diabetic Potently block the Mproenzyme Mimusopscaffra, Ilex paraguarieni, and Glechoma hederacea (Son et al. 2020)
Ellagic Acid Anti-oxidant and anti-proliferative, Inhibit fibrosis, oxidative stress, and inflammation in the diabetic liver Inhibits the Mpro and RdRp; Prevent viral attachment and internalization to the host cell Raspberries, Strawberries, Pomegranate, Persimmon, Grapes, Black Currants, Plumes, Mango, Guava, Walnuts, Almonds, Longan seeds, Green Tea, and Momordica charantia (Ríos et al. 2018)
Vanillin Anti-clastogenic, anti-microbial agent, anti-oxidant MPro inhibition Vanilla bean (Yadav et al. 2018)
Thymol Anti-oxidant, local anesthetic, anti-carcinogenesis, anti-nociceptive, cicatrizing, antiseptic, as well as a potential as a growth enhancer and immunomodulator Inhibit the viral spike protein; prevent the SARS-CoV-2 entry, potent disinfectants. Thymus vulgaris, Ocimum, Origanum, and Monarda genera (Kowalczyk et al. 2020)

In this review the important phytochemical compounds with a potential anti-viral activity have been mentioned and a prove of anti-Covid-19 has been reported to put a focus on the medicinal plants that produce a high concentration of the mentioned compounds. Obviously, small polyphenolic and terpenoid compounds have a different role in anti-viral activity through, protease inhibition like Mpro, effect on spike proteins, virus attachment, and virus replication. Needless to say, these notable in vitro and in vivo studies Required to determine the safety and therapeutic utility of each compound. Concentrations prior to human clinical trials to be conducted. To Developing an effective COVID-19 treatment and using it in first study ecules already approved by the FDA or considered safe for drugs use the same as for the polyphenol component. It is expected that the botanical ingredients described in this report support the development of natural, effective and safe anti-SARS-CoV-2 treatment options got a connection.

Acknowledgements

The author is grateful to the Middle East University (MEU), Amman, Jordan, for the financial support granted to cover the publication fee of this research article.

References

  • Adelusi TI, Oyedele A-QK, Monday OE, Boyenle ID, Idris MO, Ogunlana AT, Ayoola AM, Fatoki JO, Kolawole OE, David KB, Olayemi AA (2022) Dietary polyphenols mitigate SARS-CoV-2 main protease (Mpro)–Molecular dynamics, molecular mechanics, and density functional theory investigations. Journal of Molecular Structure 1250: 131879. https://doi.org/10.1016/j.molstruc.2021.131879
  • Adem Ş, Eyupoglu V, Sarfraz I, Rasul A, Zahoor AF, Ali M, Abdalla M, Ibrahim IM, Elfiky AA (2021) Caffeic acid derivatives (CAFDs) as inhibitors of SARS-CoV-2: CAFDs-based functional foods as a potential alternative approach to combat COVID-19. Phytomedicine 85: 153310. https://doi.org/10.1016/j.phymed.2020.153310
  • Ahmad A, Mishra RK, Vyawahare A, Kumar A, Rehman MU, Qamar W, Khan AQ, Khan R (2019) Thymoquinone (2-Isopropyl-5-methyl-1, 4-benzoquinone) as a chemopreventive/anticancer agent: Chemistry and biological effects. Saudi Pharmaceutical Journal 27: 1113–1126. https://doi.org/10.1016/j.jsps.2019.09.008
  • Alam M, Ali S, Ahmed S, Elasbali AM, Adnan M, Islam A, Hassan MI, Yadav DK (2021a) Therapeutic potential of ursolic acid in cancer and diabetic neuropathy diseases. International Journal of Molecular Sciences 22(22): 12162. https://doi.org/10.3390/ijms222212162
  • Alam M, Ali S, Mohammad T, Hasan GM, Yadav DK, Hassan MI (2021b) B Cell Lymphoma 2: A potential therapeutic target for cancer therapy. International Journal of Molecular Sciences 22(19): 10442. https://doi.org/10.3390/ijms221910442
  • Ali S, Alam M, Khatoon F, Fatima U, Elasbali AM, Adnan M, Islam A, Hassan MI, Snoussi M, De Feo V (2022) Natural products can be used in therapeutic management of COVID-19: Probable mechanistic insights. Biomedicine & Pharmacotherapy 147: 112658. https://doi.org/10.1016/j.biopha.2022.112658
  • Ali S, Ehtram A, Arora N, Manjunath P, Roy D, Ehtesham NZ, Hasnain SE (2021) The M. tuberculosis Rv1523 Methyltransferase promotes drug resistance through methylation-mediated cell wall remodeling and modulates macrophages immune responses. Frontiers in Cellular and Infection Microbiology 11: 622487. https://doi.org/10.3389/fcimb.2021.622487
  • Aucoin M, Cooley K, Saunders PR, Cardozo V, Remy D, Cramer H, Neyre Abad C, Hannan N (2020) The effect of quercetin on the prevention or treatment of COVID-19 and other respiratory tract infections in humans: A rapid review. Advances in Integrative Medicine 7: 247–251. https://doi.org/10.1016/j.aimed.2020.07.007
  • Banerjee S, Kaseb AO, Wang Z, Kong D, Mohammad M, Padhye S, Sarkar FH, Mohammad RM (2009) Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer. Cancer Research 69: 5575–5583. https://doi.org/10.1158/0008-5472.CAN-08-4235
  • Chaieb K, Kouidhi B, Jrah H, Mahdouani K, Bakhrouf A (2011) Antibacterial activity of Thymoquinone, an active principle of Nigella sativa and its potency to prevent bacterial biofilm formation. BMC Complementary and Alternative Medicine 11: 29. https://doi.org/10.1186/1472-6882-11-29
  • Chu DKW, Pan Y, Cheng SMS, Hui KPY, Krishnan P, Liu Y, Ng DYM, Wan CKC, Yang P, Wang Q, Peiris M, Poon LLM (2020) Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia. Clinical Chemistry 66: 549–555. https://doi.org/10.1093/clinchem/hvaa029
  • Colunga Biancatelli RML, Berrill M, Catravas JD, Marik PE (2020) Quercetin and vitamin C: an experimental, synergistic therapy for the prevention and treatment of SARS-CoV-2 related disease (COVID-19). Frontiers in Immunology 11: 1451. https://doi.org/10.3389/fimmu.2020.01451
  • Cortegiani A, Ingoglia G, Ippolito M, Giarratano A, Einav S (2020) A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. Journal of Critical Care 57: 279–283. https://doi.org/10.1016/j.jcrc.2020.03.005
  • Derosa G, Maffioli P, Sahebkar A (2016) Ellagic acid and its role in chronic diseases. In: Gupta SC, Prasad S, Aggarwal BB (Eds) Anti-inflammatory Nutraceuticals and Chronic Diseases. Springer International Publishing, Cham, 473–479. https://doi.org/10.1007/978-3-319-41334-1_20
  • El-Seedi HR, El-Said AMA, Khalifa SAM, Göransson U, Bohlin L, Borg-Karlson A-K, Verpoorte R (2012) Biosynthesis, natural sources, dietary intake, pharmacokinetic properties, and biological activities of hydroxycinnamic acids. Journal of Agricultural and Food Chemistry 60: 10877–10895. https://doi.org/10.1021/jf301807g
  • El Gazzar M, El Mezayen R, Marecki JC, Nicolls MR, Canastar A, Dreskin SC (2006) Anti-inflammatory effect of thymoquinone in a mouse model of allergic lung inflammation. International Immunopharmacology 6: 1135–1142. https://doi.org/10.1016/j.intimp.2006.02.004
  • Evtyugin DD, Magina S, Evtuguin DV (2020) Recent advances in the production and applications of ellagic acid and its derivatives. A Review. Molecules 25(12): 2745. https://doi.org/10.3390/molecules25122745
  • García-Niño WR, Zazueta C (2015) Ellagic acid: Pharmacological activities and molecular mechanisms involved in liver protection. Pharmacological Research 97: 84–103. https://doi.org/10.1016/j.phrs.2015.04.008
  • Ghamry HI, Belal A, El-Ashrey MK, Tawfik HO, Alsantali RI, Obaidullah AJ, El-Mansi AA, Abdelrahman D (2023) Evaluating the ability of some natural phenolic acids to target the main protease and AAK1 in SARS COV-2. Scientific Reports 13: 7357. https://doi.org/10.1038/s41598-023-34189-6
  • Grochowicz U, Kułakowski P, Jurgiel R, Budaj A, Dłuzniewski M (1988) Susceptibility to the development of supraventricular arrhythmia in patients with mitral valve prolapse syndrome. Polski Tygodnik Lekarski 43: 1323–1324.
  • Heinz SA, Henson DA, Austin MD, Jin F, Nieman DC (2010) Quercetin supplementation and upper respiratory tract infection: A randomized community clinical trial. Pharmacological Research 62: 237–242. https://doi.org/10.1016/j.phrs.2010.05.001
  • Henson D, Nieman D, Davis JM, Dumke C, Gross S, Murphy A, Carmichael M, Jenkins DP, Quindry J, Mcanulty S, Mcanulty L, Utter A, Mayer E (2008) Post-160-km race illness rates and decreases in granulocyte respiratory burst and salivary IgA output are not countered by quercetin ingestion. International Journal of Sports Medicine 29: 856–863. https://doi.org/10.1055/s-2007-989424
  • Henson DA, Nieman DC, Davis JM, Murphy EA, Carmichael MD, Dumke CL, Gross SJ, Jenkins DP, Quindry JC, Mcanulty SR, Mcanulty LS, Utter AC, Mayer EP (2007) Post-160-km race illness rates and decreases in granulocyte oxidative burst activity and salivary IgA output are not countered by quercetin ingestion. The FASEL Journal 21(6): A1249–A1249. https://doi.org/10.1096/fasebj.21.6.A1249-a
  • Hussain H, Green IR, Ali I, Khan IA, Ali Z, Al-Sadi AM, Ahmed I (2017) Ursolic acid derivatives for pharmaceutical use: a patent review (2012–2016). Expert Opinion on Therapeutic Patents 27: 1061–1072. https://doi.org/10.1080/13543776.2017.1344219
  • Jaber SA (2021) Natural products are a precious source of the new bioactive compounds. PharmacologyOnline 3: 1299–1312.
  • Jaber SA, Saadh M (2023) Comparison of the efficacy of one, two, and third doses of BNT162b2 in patients suffering from cardiovascular diseases, respiratory diseases, and diabetes against COVID-19. Pharmacia 70: 155–159. https://doi.org/10.3897/pharmacia.70.e97777
  • Khader M, Eckl PM (2014) Thymoquinone: an emerging natural drug with a wide range of medical applications. Iranian Journal of Basic Medical Sciences 17: 950–957.
  • Khamitov R, Sia L, Shchukina V, Borisevich S, Maksimov V, Shuster AJVV (2008) Antiviral activity of arbidol and its derivatives against the pathogen of severe acute respiratory syndrome in the cell cultures. Voprosy virusologii 53: 9–13.
  • Kowalczyk A, Przychodna M, Sopata S, Bodalska A, Fecka I (2020) Thymol and thyme essential oil – new insights into selected therapeutic applications. Molecules 25(18): 4125. https://doi.org/10.3390/molecules25184125
  • Kulkarni SA, Nagarajan SK, Ramesh V, Palaniyandi V, Selvam SP, Madhavan T (2020) Computational evaluation of major components from plant essential oils as potent inhibitors of SARS-CoV-2 spike protein. Journal of Molecular Structure 1221: 128823. https://doi.org/10.1016/j.molstruc.2020.128823
  • Kumar A, Choudhir G, Shukla SK, Sharma M, Tyagi P, Bhushan A, Rathore M (2021) Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches. Journal of Biomolecular Structure and Dynamics 39: 3760–3770. https://doi.org/10.1080/07391102.2020.1772112
  • Law WY, Asaruddin MR, Bhawani SA, Mohamad S (2020) Pharmacophore modelling of vanillin derivatives, favipiravir, chloroquine, hydroxychloroquine, monolaurin and tetrodotoxin as MPro inhibitors of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). BMC Research Notes 13: 527. https://doi.org/10.1186/s13104-020-05379-6
  • López-Hortas L, Pérez-Larrán P, González-Muñoz MJ, Falqué E, Domínguez H (2018) Recent developments on the extraction and application of ursolic acid. A review. Food Research International 103: 130–149. https://doi.org/10.1016/j.foodres.2017.10.028
  • Lu G, Wang Q, Gao GF (2015) Bat-to-human: spike features determining ‘host jump’ of coronaviruses SARS-CoV, MERS-CoV, and beyond. Trends in Microbiology 23: 468–478. https://doi.org/10.1016/j.tim.2015.06.003
  • Malini P, Kanchana G, Rajadurai M (2011) Antibiabetic efficacy of ellagic acid in streptozotoc-ininduced diabetes mellitus in albino wistar rats. Asian Journal of Pharmaceutical and Clinical Research 4: 124–128.
  • Marchese A, Orhan IE, Daglia M, Barbieri R, Di Lorenzo A, Nabavi SF, Gortzi O, Izadi M, Nabavi SM (2016) Antibacterial and antifungal activities of thymol: A brief review of the literature. Food Chemistry, 210: 402–414. https://doi.org/10.1016/j.foodchem.2016.04.111
  • Mitra D, Verma D, Mahakur B, Kamboj A, Srivastava R, Gupta S, Pandey A, Arora B, Pant K, Panneerselvam P (2021) Molecular docking and simulation studies of natural compounds of Vitex negundo L. against papain-like protease (PLpro) of SARS CoV-2 (coronavirus) to conquer the pandemic situation in the world. Journal of Biomolecular Structure and Dynamics 40(12): 5665–5686. https://doi.org/10.1080/07391102.2021.1873185
  • Naz H, Tarique M, Khan P, Luqman S, Ahamad S, Islam A, Ahmad F, Hassan MI (2018) Evidence of vanillin binding to CAMKIV explains the anti-cancer mechanism in human hepatic carcinoma and neuroblastoma cells. Molecular and Cellular Biochemistry 438: 35–45. https://doi.org/10.1007/s11010-017-3111-0
  • Nieman DC, Henson DA, Gross SJ, Jenkins DP, Davis JM, Murphy EA, Carmichael MD, Dumke CL, Utter AC, Mcanulty SRJM, Sports SI (2007) Quercetin reduces illness but not immune perturbations after intensive exercise. Medicine & Science in Sports & Exercise 39: 1561–1569. https://doi.org/10.1249/mss.0b013e318076b566
  • Núñez S, Moliner C, Valero MS, Mustafa AM, Maggi F, Gómez-Rincón C, López V (2023) Antidiabetic and anti-obesity properties of a polyphenol-rich flower extract from Tagetes erecta L. and its effects on Caenorhabditis elegans fat storages. Journal of Physiology and Biochemistry 79: 427–440. https://doi.org/10.1007/s13105-023-00953-5
  • Ogawa M, Shirasago Y, Ando S, Shimojima M, Saijo M, Fukasawa M (2018) Caffeic acid, a coffee-related organic acid, inhibits infection by severe fever with thrombocytopenia syndrome virus in vitro. Journal of Infection and Chemotherapy 24: 597–601. https://doi.org/10.1016/j.jiac.2018.03.005
  • Pang J, Wang MX, Ang IYH, Tan SHX, Lewis RF, Chen JI-P, Gutierrez RA, Gwee SXW, Chua PEY, Yang Q, Ng XY, Yap RKS, Tan HY, Teo YY, Tan CC, Cook AR, Yap JC-H, Hsu LY (2020) Potential rapid diagnostics, vaccine and therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review 9: 623. https://doi.org/10.3390/jcm9030623
  • Paracatu LC, Faria CMQG, Quinello C, Rennó C, Palmeira P, Zeraik ML, Da Fonseca LM, Ximenes VF (2014) Caffeic acid phenethyl ester: Consequences of its hydrophobicity in the oxidative functions and cytokine release by leukocytes. Evidence-based Complementary and Alternative Medicine 2014: 793629. [13 pp] https://doi.org/10.1155/2014/793629
  • Pawlotsky J-M (2014) New hepatitis C virus (HCV) drugs and the hope for a cure: concepts in anti-HCV drug development. Seminars in Liver Disease 34: 022–029. https://doi.org/10.1055/s-0034-1371007
  • Pironi AM, De Araújo PR, Fernandes MA, Salgado HRN, Chorilli M (2018) Characteristics, biological properties and analytical methods of ursolic acid: A Review. Critical Reviews in Analytical Chemistry 48: 86–93. https://doi.org/10.1080/10408347.2017.1390425
  • Rana R, Joon S, Chauhan K, Rathi V, Ganguly KN, Kumari C, Yadav KD (2021a) Role of extracellular vesicles in glioma progression: deciphering cellular biological processes to clinical applications. Current Topics in Medicinal Chemistry 21: 696–704. https://doi.org/10.2174/1568026620666201207100139
  • Rana R, Rathi V, Chauhan K, Jain K, Chhabra SS, Acharya R, Kalra SK, Gupta A, Jain S, Ganguly NK, Yadav DK (2021b) Exploring the role of epidermal growth factor receptor variant III in meningeal tumors. PLоS ONE 16: e0255133. https://doi.org/10.1371/journal.pone.0255133
  • Refaat H, Mady FM, Sarhan HA, Rateb HS, Alaaeldin E (2021) Optimization and evaluation of propolis liposomes as a promising therapeutic approach for COVID-19. International Journal of Pharmaceutics 592: 120028.
  • Saeed M, Naveed M, Bibi J, Kamboh AA, Arain MA, Shah QA, Alagawany M, El-Hack MEA, Abdel-Latif MA, Yatoo MI, Tiwari R, Chakraborty S, Dhama K (2018) The promising pharmacological effects and therapeutic/medicinal applications of Punica granatum L. (pomegranate) as a functional food in humans and animals. Recent Patents on Inflammation and Allergy Drug Discovery 12: 24–38. https://doi.org/10.2174/1872213X12666180221154713
  • Sanati M, Afshari AR, Amini J, Mollazadeh H, Jamialahmadi T, Sahebkar A (2022) Targeting angiogenesis in gliomas: Potential role of phytochemicals. Journal of Functional Foods 96: 105192. https://doi.org/10.1016/j.jff.2022.105192
  • Shinozuka K, Kikuchi Y, Nishino C, Mori A, Tawata S (1988) Inhibitory effect of flavonoids on DNA-dependent DNA and RNA polymerases. Experientia 44: 882–885. https://doi.org/10.1007/BF01941188
  • Singh DD, Verma R, Parimoo P, Sahu A, Kumar V, Upadhyay E, Yadav KD (2021a) Potential therapeutic relevance of CRISPR/Cas9 guided epigenetic regulations for neuropsychiatric disorders. Current Topics in Medicinal Chemistry 21: 878–894. https://doi.org/10.2174/1568026621666210317154502
  • Singh DD, Verma R, Tripathi KS, Sahu R, Trivedi P, Yadav KD (2021b) Breast cancer transcriptional regulatory network reprogramming by using the CRISPR/Cas9 system: an oncogenetics perspective. Current Topics in Medicinal Chemistry 21: 2800–2813. https://doi.org/10.2174/1568026621666210902120754
  • Sohrabi C, Alsafi Z, O’neill N, Khan M, Kerwan A, Al-Jabir A, Iosifidis C, Agha R (2020) World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International Journal of Surgery 76: 71–76. https://doi.org/10.1016/j.ijsu.2020.02.034
  • Son J, Vo TN, Cho S, Preman AN, Kim IT, Ahn SK (2020) Acrylic random copolymer and network binders for silicon anodes in lithium-ion batteries. Journal of Power Sources 458: 228054. https://doi.org/10.1016/j.jpowsour.2020.228054
  • Son S, Lewis BA (2002) Free radical scavenging and antioxidative activity of caffeic acid amide and ester analogues: Structure-activity relationship. Journal of Agricultural and Food Chemistry 50: 468–472. https://doi.org/10.1021/jf010830b
  • Souid I, Korchef A, Souid S (2022) In silico evaluation of Vitis amurensis Rupr. Polyphenol compounds for their inhibition potency against COVID-19 main enzymes Mpro and RdRp. Saudi Pharmaceutical Journal 30: 570–584. https://doi.org/10.1016/j.jsps.2022.02.014
  • Sova M, Saso L (2020) Natural sources, pharmacokinetics, biological activities and health benefits of hydroxycinnamic acids and their metabolites. Nutrients 12(8): 2190. https://doi.org/10.3390/nu12082190
  • Tai A, Sawano T, Yazama F, Ito H (2011) Evaluation of antioxidant activity of vanillin by using multiple antioxidant assays. Biochimica et Biophysica Acta (BBA) – General Subjects 1810: 170–177. https://doi.org/10.1016/j.bbagen.2010.11.004
  • Turab Naqvi AA, Hasan MG, Hassan IM (2020) Targeting tau hyperphosphorylation via kinase inhibition: strategy to address alzheimer’s disease. Current Topics in Medicinal Chemistry 20: 1059–1073. https://doi.org/10.2174/1568026620666200106125910
  • Utsunomiya H, Ichinose M, Ikeda K, Uozaki M, Morishita J, Kuwahara T, Koyama AH, Yamasaki H (2014) Inhibition by caffeic acid of the influenza A virus multiplication in vitro. International Journal of Molecular Medicine 34: 1020–1024. https://doi.org/10.3892/ijmm.2014.1859
  • Wan S, Xiang Y, Fang W, Zheng Y, Li B, Hu Y, Lang C, Huang D, Sun Q, Xiong Y, Huang X, Lv J, Luo Y, Shen L, Yang H, Huang G, Yang R (2020) Clinical features and treatment of COVID-19 patients in northeast Chongqing. Journal of Medical Virology 92(7): 797–806. https://doi.org/10.1002/jmv.25783
  • Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, Meng J, Zhu Z, Zhang Z, Wang J, Sheng J, Quan L, Xia Z, Tan W, Cheng G, Jiang T (2020a) Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host & Microbe 27: 325–328. https://doi.org/10.1016/j.chom.2020.02.001
  • Wu C, Liu Y, Yang Y, Zhang P, Zhong W, Wang Y, Wang Q, Xu Y, Li M, Li X, Zheng M, Chen L, Li H (2020b) Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica B 10: 766–788. https://doi.org/10.1016/j.apsb.2020.02.008
  • Xiao Y, Huang R, Wang N, Deng Y, Tan B, Yin Y, Qi M, Wang J (2022) Ellagic acid alleviates oxidative stress by mediating Nrf2 signaling pathways and protects against paraquat-induced intestinal injury in piglets. Antioxidants 11(2): 252. https://doi.org/10.3390/antiox11020252
  • Xu H, Liu B, Xiao Z, Zhou M, Ge L, Jia F, Liu Y, Jin H, Zhu X, Gao J, Akhtar J, Xiang B, Tan K, Wang G (2021) Computational and experimental studies reveal that thymoquinone blocks the entry of coronaviruses into in vitro cells. Infectious Diseases and Therapy 10: 483–494. https://doi.org/10.1007/s40121-021-00400-2
  • Yadav PK, Jaiswal A, Singh RK (2022) In silico study on spice-derived antiviral phytochemicals against SARS-CoV-2 TMPRSS2 target. Journal of Biomolecular Structure and Dynamics 40: 11874–11884. https://doi.org/10.1080/07391102.2021.1965658
  • Yadav R, Saini D, Yadav D (2018) Synthesis and evaluation of vanillin derivatives as antimicrobial agents. Turkish Journal of Pharmaceutical Sciences 15: 57–62. https://doi.org/10.4274/tjps.97752
  • Yang Y, Islam MS, Wang J, Li Y, Chen X (2020a) Traditional chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): A review and perspective. International Journal of Biological Sciences 16: 1708–1717. https://doi.org/10.7150/ijbs.45538
  • Yang Y, Peng F, Wang R, Guan K, Jiang T, Xu G, Sun J, Chang C (2020b) The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. Journal of Autoimmunity 109: 102434. https://doi.org/10.1016/j.jaut.2020.102434
  • Yousuf M, Khan P, Shamsi A, Shahbaaz M, Hasan GM, Haque QMR, Christoffels A, Islam A, Hassan MI (2020) Inhibiting CDK6 activity by quercetin is an attractive strategy for cancer therapy. ACS Omega 5: 27480–27491. https://doi.org/10.1021/acsomega.0c03975
  • Yousuf M, Shamsi A, Queen A, Shahbaaz M, Khan P, Hussain A, Alajmi MF, Rizwanul Haque QM, Imtaiyaz Hassan M (2021) Targeting cyclin-dependent kinase 6 by vanillin inhibits proliferation of breast and lung cancer cells: Combined Computational and Biochemical Studies 122: 897–910. https://doi.org/10.1002/jcb.29921
  • Zhang D, Zhang B, Lv J-T, Sa R-N, Zhang X-M, Lin Z-J (2020) The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence. Pharmacological Research 157: 104882. https://doi.org/10.1016/j.phrs.2020.104882
login to comment